Cost Saving or Cost Effective? Unanswered Questions in the Screening of Patients With Nonalcoholic Fatty Liver Disease

Hepatol Commun. 2019 Oct 1;3(10):1293-1295. doi: 10.1002/hep4.1386. eCollection 2019 Oct.
No abstract available

Publication types

  • Editorial